Dr Reddy‘s Laboratory and Lupin are top picks of Nomura India's Saion Mukherjee. He expects Sun Pharma to come off from current highs and see operational improvement in Ranbaxy.
first published: May 29, 2013 03:42 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell
Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more
How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
